AVIC Avionics:Margins for modernization;initiating with Buy

类别:公司研究 机构:德意志银行 研究员:Nick Zheng,Sky Hong 日期:2015-12-28

Superior returns and restructuring potential justify premium valuation; Buy

    AVIC Avionics is one of China's largest suppliers of avionics, the "brain"system of an aircraft. High entry barrier enables the company to enjoy superiorreturns vs. its peers. We expect its earnings to return to growth trajectory in2015 and further accelerate during 2016-2017 (20% CAGR in 2015-2017). Wesee value-accretive asset injections as a key catalyst for the stock. We initiatecoverage with a Buy rating and a P/E based target price of Rmb32.

    Riding on China’s military aircraft upgrade cycle

    We believe rising budget allocation to military aircraft procurement is set tobenefit the domestic avionics market, which is currently dominated by AVICAvionics. Unlike domestic military airframers, component suppliers are lessexposed to product concentration risk, with better pricing power, hence higherprofitability. The imminent avionics upgrade cycle for PLA’s existing air fleet, ifmaterialized, could yield upside potential to our forecasts in the coming years.

    Value-accretive asset injections on the horizon

    Positioned as the ultimate listing platform for AVIC’s avionics segment, webelieve further asset injections into AVIC Avionics are conceivable givensubstantial assets still remain at AVIC with sizable profits. Currently, the listcois managing these assets via entrustment agreement, making further assetinjection a sensible next move, in our view. Our scenario analysis suggeststhese asset injections, if they take place, could enhance AVIC Avionics’ 2016Eearnings by as much as 164%.

    Valuation and risks

    Our target price of Rmb32 is derived based on 67x FY16E EPS, a 20% premiumto its historical mid-cycle P/E in the past five years. We believe such premiumis justified given accelerated growth and upside potential from avionicsreplacement cycle. Moreover, potential asset injections, if materialized, couldbring down our target P/E to 25x. Key risks include an unexpected decrease inChina’s military spending and delay in asset restructuring.

股票代码 股票名称 最新价(元) 涨跌额(元) 涨跌幅(%) 成交额(万元) 成交量(手)
600372 @nn@ @n@ @c@ @cc@ @v@ @t@

数据推荐

投资评级

更多>>
股票名称最新评级目标价研报

盈利预测

评级选股>>
股票名称11年EPS12年EPS研报
新城控股 0 0 研报
光大嘉宝 0.60 0 研报
世联行 0.84 0.62 研报
大悦城 0.30 0.27 研报
蓝光发展 0.24 0 研报
荣盛发展 0.75 1.04 研报
绿地控股 0.55 0.30 研报
中南建设 0.80 0.99 研报
金融街 0.64 0.72 研报
新湖中宝 0.38 0.32 研报
金地集团 0.67 0.71 研报

股票关注度

更多>>
股票名称关注度平均评级最新评级
海康威视 6 持有 买入
华夏幸福 4 买入 买入
恒逸石化 4 买入 买入
南极电商 4 买入 买入
洽洽食品 4 持有 买入
贵州茅台 3 持有 买入
普洛药业 3 买入 买入
旗滨集团 3 买入 买入
喜临门 3 买入 买入
中南建设 3 买入 买入
比音勒芬 2 买入 持有
吉比特 2 持有 买入
完美世界 2 持有 买入
万科A 2 买入 买入
大悦城 2 买入 买入
美的集团 2 买入 买入
新经典 2 持有 中性

行业关注度

更多>>
行业名称关注度关注股票数买入评级数